Compare Moderna, Inc. (MRNA) vs PPG Industries, Inc. (PPG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs PPG Industries, Inc. — how do they compare? Moderna, Inc. trades at $136.93 (market cap $54.14B), while PPG Industries, Inc. trades at $107.16 (market cap $23.82B). The key difference: Moderna, Inc. is far larger — about 2.3× PPG Industries, Inc.'s market cap, and PPG Industries, Inc. pays a 2.76% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | PPG | |
|---|---|---|
Market Cap | $54.14B | $23.82B |
Sector | Health | Basic Materials |
52-Week High | $174.38 | $131.56 |
52-Week Low | $22.36 | $94.34 |
Enterprise Value | $50.29B | $29.69B |
Dividend Yield | — | 2.76% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Moderna (MRNA) trades at $140.33, down 3.59% on the day, amid mixed signals. The stock has seen volatility, with a 143% surge over the past month driven by positive cancer vaccine trial results (Fox Business, 2026-09-06), but faces headwinds from declining revenue and persistent net losses. Technical analysis shows a bullish overall signal, with support at $138 and resistance at $145, while fundamentals reveal a challenging profit margin of -142.58% for 2026.
The outlook hinges on pipeline successes, particularly in oncology, but high valuation ratios and competitive pressures pose risks. Analyst consensus is cautious, with a $90.08 price target, reflecting skepticism despite recent clinical milestones. Investors should weigh innovation potential against financial sustainability and market sentiment shifts.
PPG Industries trades at $109.72, down 2.5% for the day, with a bearish technical outlook as it hovers near support at $109. Fundamentally, the company reported Q2 2026 EPS of $2.23, missing estimates, but maintains solid profitability with a net margin of 9.57% and ROE of 19.63%. Recent news highlights product innovations like the ONE RANGE marine coatings and leadership appointments aimed at growth.
The stock offers value with a P/E of 15.74 below industry averages and a 55% analyst buy rating, targeting $129.17 upside. Risks include volatile earnings performance and economic sensitivity in coatings demand. Cash flow stability and dividend payments provide shareholder support amid near-term headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About PPG Industries, Inc.
PPG is a global producer of coatings. The company is the world's largest producer of coatings after the purchase of selected Akzo Nobel assets. PPG's products are sold to a wide variety of end users, including the automotive, aerospace, construction, and industrial markets. The company has a footprint in many regions around the globe, with less than half of sales coming from North America in recent years. PPG is focused on its coatings and specialty products and expansion into emerging regions, as exemplified by the Comex acquisition.
Read more on PPG →
